October 02-04, 2026
Omni Frisco Hotel – Frisco, TX
VITESSE phase 3 trial: efficacy and safety of epicutaneous immunotherapy in peanut-allergic children 4 through 7 years of age
View Poster
SHC Congress 2026
Detailed Information
Meeting Date:
10/02/2026